Home›Research›Compare›ARA-290 vs Cortagen
Peptide Comparison
ARA-290 vs Cortagen
Both are Longevity peptides.
Cortagen
vascular peptide bioregulator
No providers listed yet
Quick Verdict
ARA-290
Risk
Half-life
~3 hours
Cortagen
Risk
Half-life
—
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About Cortagen
Vascular-targeted peptide complex that modulates endothelial cell gene expression. May support nitric oxide production, reduce vascular inflammation, and improve endothelial function.
A short peptide bioregulator derived from blood vessel tissue, developed by the Khavinson Institute. Studied for cardiovascular function support and mitigation of age-related vascular deterioration.
Research Areas
Find Providers
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.